These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24976857)

  • 1. Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia.
    Díez A; Cieza-Borrella C; Suazo V; González-Sarmiento R; Papiol S; Molina V
    Ann Gen Psychiatry; 2014; 13():18. PubMed ID: 24976857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain.
    Kao WT; Wang Y; Kleinman JE; Lipska BK; Hyde TM; Weinberger DR; Law AJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15619-24. PubMed ID: 20713722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population.
    Moon E; Rollins B; Mesén A; Sequeira A; Myers RM; Akil H; Watson SJ; Barchas J; Jones EG; Schatzberg A; Bunney WE; DeLisi LE; Byerley W; Vawter MP
    Schizophr Res; 2011 Sep; 131(1-3):52-7. PubMed ID: 21745728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Paterson C; Wang Y; Hyde TM; Weinberger DR; Kleinman JE; Law AJ
    Am J Psychiatry; 2017 Mar; 174(3):256-265. PubMed ID: 27771971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia.
    Zhou Y; Li Y; Meng Y; Wang J; Wu F; Ning Y; Li Y; Cassidy RM; Li Z; Zhang XY
    Transl Psychiatry; 2020 Feb; 10(1):62. PubMed ID: 32066712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRG3 contributes to cognitive deficits in chronic patients with schizophrenia.
    Li Z; Liu L; Lin W; Zhou Y; Zhang G; Du X; Li Y; Tang W; Zhang X
    Schizophr Res; 2020 Jan; 215():134-139. PubMed ID: 31753594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuregulin 3 genotype on human prefrontal cortex physiology.
    Tost H; Callicott JH; Rasetti R; Vakkalanka R; Mattay VS; Weinberger DR; Law AJ
    J Neurosci; 2014 Jan; 34(3):1051-6. PubMed ID: 24431462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a Missense Polymorphism (rs3924999, Arg253Gln) of Neuregulin 1 and Schizophrenia in Korean Population.
    Yang SA
    Exp Neurobiol; 2012 Dec; 21(4):158-63. PubMed ID: 23319876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition.
    Hong LE; Wonodi I; Stine OC; Mitchell BD; Thaker GK
    Biol Psychiatry; 2008 Jan; 63(1):17-23. PubMed ID: 17631867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample.
    Kukshal P; Bhatia T; Bhagwat AM; Gur RE; Gur RC; Deshpande SN; Nimgaonkar VL; Thelma BK
    Schizophr Res; 2013 Mar; 144(1-3):24-30. PubMed ID: 23360725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males.
    Roussos P; Giakoumaki SG; Adamaki E; Bitsios P
    Biol Psychiatry; 2011 Mar; 69(5):479-86. PubMed ID: 21035784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.
    Schmitt A; Parlapani E; Gruber O; Wobrock T; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():35-9. PubMed ID: 18985292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia-risk variant rs6994992 in the neuregulin-1 gene on brain developmental trajectories in typically developing children.
    Douet V; Chang L; Pritchett A; Lee K; Keating B; Bartsch H; Jernigan TL; Dale A; Akshoomoff N; Murray S; Bloss C; Kennedy DN; Amaral D; Gruen J; Kaufmann WE; Casey BJ; Sowell E; Ernst T
    Transl Psychiatry; 2014 May; 4(5):e392. PubMed ID: 24865593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood.
    Paterson C; Law AJ
    PLoS One; 2014; 9(8):e104172. PubMed ID: 25093331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.
    Paterson C; Wang Y; Kleinman JE; Law AJ
    Am J Psychiatry; 2014 Sep; 171(9):979-89. PubMed ID: 24935406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals.
    Cho Y; Ryu S; Huh I; Cho EY; Oh H; Lee YS; Lee WK; Park T; Kwon JS; Hong KS
    Psychiatr Genet; 2015 Aug; 25(4):147-54. PubMed ID: 25967537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population.
    Pasaje CF; Bae JS; Park BL; Cheong HS; Kim JH; Park TJ; Lee JS; Kim Y; Park CS; Kim BJ; Cha B; Kim JW; Choi WH; Shin TM; Choi IG; Hwang J; Shin HD; Woo SI
    Genes Brain Behav; 2011 Nov; 10(8):828-33. PubMed ID: 21762460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse.
    Long LE; Anderson P; Frank E; Shaw A; Liu S; Huang XF; Pinault D; Karl T; O'Brien TJ; Shannon Weickert C; Jones NC
    PLoS One; 2015; 10(5):e0124114. PubMed ID: 25992564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.
    Vullhorst D; Ahmad T; Karavanova I; Keating C; Buonanno A
    J Neurosci; 2017 May; 37(21):5232-5249. PubMed ID: 28432142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
    Deng C; Pan B; Engel M; Huang XF
    Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.